Literature DB >> 18272636

Approach to primary care follow-up of patients with prostate cancer.

Anna N Wilkinson1, Michael D Brundage, Robert Siemens.   

Abstract

OBJECTIVE: To review resources available to aid family physicians in their care of prostate cancer patients and develop an algorithm to summarize these findings. SOURCES OF INFORMATION: MEDLINE, EMBASE, and relevant website search. All relevant guidelines were level III evidence. MAIN MESSAGE: Improved screening and treatment of patients with prostate cancer is resulting in an increasing number of survivors. These men require ongoing monitoring, a responsibility that is largely falling to family physicians. We review the expected prostate-specific antigen (PSA) responses to different prostate cancer treatment modalities and provide an appropriate schedule of follow-up and monitoring techniques for prostate cancer patients.
CONCLUSION: In light of the paucity of resources for family physicians in their ongoing care of prostate cancer patients, we present an algorithm, primarily based on PSA kinetics, for practical use in the continuing care of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272636      PMCID: PMC2278312     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  27 in total

Review 1.  The management of prostate cancer in patients with a rising prostate-specific antigen level.

Authors:  J Fichtner
Journal:  BJU Int       Date:  2000-07       Impact factor: 5.588

2.  PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.

Authors:  Alain Toledano; Laurent Chauveinc; Thierry Flam; Nicolas Thiounn; Suzette Solignac; Michel Timbert; Jean-Claude Rosenwald; Jean-Marc Cosset
Journal:  Brachytherapy       Date:  2006 Apr-Jun       Impact factor: 2.362

3.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Authors:  Mack Roach; Gerald Hanks; Howard Thames; Paul Schellhammer; William U Shipley; Gerald H Sokol; Howard Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-15       Impact factor: 7.038

4.  Active surveillance with selective delayed intervention for favorable risk prostate cancer.

Authors:  Laurence Klotz
Journal:  Urol Oncol       Date:  2006 Jan-Feb       Impact factor: 3.498

5.  Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

Authors: 
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

6.  PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

Authors:  Jay P Ciezki; Chandana A Reddy; Jorge Garcia; Kenneth Angermeier; James Ulchaker; Arul Mahadevan; Nabil Chehade; Andrew Altman; Eric A Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-06       Impact factor: 7.038

7.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

Authors:  E M Messing; J Manola; M Sarosdy; G Wilding; E D Crawford; D Trump
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

8.  Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival.

Authors:  Shomik Sengupta; Michael L Blute; Stephanie M Bagniewski; Robert P Myers; Eric J Bergstralh; Bradley C Leibovich; Horst Zincke
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

9.  Efficacy of digital rectal examination after radiotherapy for prostate cancer.

Authors:  P A Johnstone; J T McFarland; R H Riffenburgh; C L Amling
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

10.  Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques.

Authors:  F A Critz; W H Williams; C T Holladay; A K Levinson; J B Benton; D A Holladay; F J Schnell; L S Maxa; P D Shrake
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

View more
  4 in total

1.  Helping patients with localized prostate cancer reach treatment decisions.

Authors:  Kathryn Birnie; John Robinson
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

2.  Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.

Authors:  Saira Khan; Sanah Vohra; Laura Farnan; Shekinah N C Elmore; Khadijah Toumbou; Madhav K C; Elizabeth T H Fontham; Edward S Peters; James L Mohler; Jeannette T Bensen
Journal:  Prostate       Date:  2022-07-26       Impact factor: 4.012

3.  Primary care follow-up of radical prostatectomy patients: A regional New Zealand experience.

Authors:  Omid Yassaie; Ben McLaughlin; Marlon Perera; Todd Manning; Nathan Lawrentschuk; Andrew Malcolm
Journal:  Prostate Int       Date:  2016-07-29

4.  Comparison of the Effect of Intra-Rectal Administration of Lidocaine Gel and Lidocaine Plus Fentanyl on Pain Reduction in Prostate Biopsy: A Randomized Clinical Trial.

Authors:  Farsad Imani; Mohammadreza Khajavi; Tayeb Gavili; Pejman Pourfakhr; Reza Shariat Moharari; Farhad Etezadi; Seyed Reza Hosseini
Journal:  Anesth Pain Med       Date:  2018-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.